History

 

 

Chattem Chemicals, Inc. has a rich history as part of Chattem, Inc,

which was founded as the Chattanooga Medicine Company on February 21, 1879. It began operations in a small unpretentious 2-story brick building located on a muddy, unpaved road called Market Street in the heart of downtown Chattanooga. Chattanooga Medicine Company was the maker of many recognizable products including Thedford’s Black Draught®, a senna based laxative, originally developed in 1840 by Dr. A.Q. Simmons of Snow Hill, Georgia.

Just after World War II, the seeds of today's Chattem Chemicals were sown.  One of the first new antacid compounds commonly known as Dihydroxy Aluminum Aminoacetate was developed.  Shortly thereafter, Dr. Irvine W. Grote, a Company advisor, discovered a second new antacid, Dihydroxy Aluminum Sodium. The fine chemicals division until recently for use in "Bufferin" and "Rolaids" manufactured these two compounds, respectively.

Internal research efforts also gave birth to "Pamabrom", a diuretic used to reduce menstrual discomfort. Pamabrom remains one of the key products manufactured today along with USP Glycine (Amino acetic Acid) for the injectable market.

In 1995 Elcat, Inc. purchased the chemical division of Chattem, giving birth to 'Chattem Chemicals, Inc.'.  Elcat was the parent company of Electrocatalytic Products, which was formed in 1986 in a management buyout from Engelhard Chemicals Co.  The company has a long history of manufacturing and engineering in the electrochemical field.  Products included CAPAC®, an impressed current cathodic protection system for full hull protection in sea going vessels. The company also manufactured Chloropac® systems, a patented electro-chlorination system to prevent fouling from bacterial growth in cooling water.

In 1998, Elcat sold Electrocatalytic to focus on the Chemicals business in Chattanooga.  In 1999, Elcat acquired Arenol, a small controlled substances manufacturer in New Jersey and move operations to its Chattanooga site. 

Today Chattem Chemicals, Inc. manufacturers a broad variety of products in four primary markets: Active Pharmaceutical Ingredients, Catalysts, Surfactants & Performance Additives. Today we are focused on growth in controlled substances in our API unit.  Our product includes several psychoactive amines, barbiturates, and methenamine salts. Chattem Chemicals most recent Drug Master Files include:  Fentanyl, Methylphenidate HCL and Methylphenidate Base, as well as its most recent DMF, Benzphetamine.  We are licensed by the DEA to manufacture schedule 1-5 controlled substances and are inspected regularly by the FDA for compliance to Good Manufacturing Practices. CCI has deep roots in the pharmaceutical industry. From beginnings in novel aluminum chemistries for antacids to the current production of controlled substances, CCI has the breadth of experience to meet a variety of needs and applications.

The core aluminum alkoxide technology that was responsible for Chattem Chemicals’ early history was also found to be useful in other applications. For almost 40 years, Chattem Chemicals, Inc. has been producing aluminum performance additives for the Ink, Paint, Grease and Petroleum industries to control the viscoelastic properties of different systems. Key Benefits of our products include; increased molecular weight, increased gloss, and increased ink film hardness. Our key products include Cyco-Gel ,Tri-XLtm, OAO, OAO-EF, Ketalin III, , Ketalin V and our newest addition , Ultra-Geltm,.  In addition to aluminum alkoxide catalysts used in named oxidation-reduction reactions, e.g.; Meerwein-Ponndorf-Verley, Oppenauer and Tischenko, Chattem Chemicals produces other aluminum compounds that are excellent sources of high purity aluminum used in the coatings, electronics & pharmaceutical industries. Our Halogard product line is as acid scavenging and chemical foaming agents in the plastics industry.

In 2004, Chattem recognized an unmet market need in the Surfactants area.  The Dow Chemical Company had made the decision to shut down its Nashua, NH Operations that housed their Hamposyltm product lines and proprietary production process.  Chattem Chemicals entered into negotiations with Dow and eventually bought the equipment and technical package and re-built the plant in Chattanooga.  The facility opened again in April of 2005.  It has been on a steady upward growth path since then and has become an all-important fourth business unit for the company.

 

Home

Products

Services

Ordering

Contacts

News/Events

History

Contact Us:

Telephone: 

(423) 822-5020; Facsimile: 

(423) 825-0507

Postal Address:

3708 St. Elmo Avenue

Chattanooga, TN  37409

Directions:

http://maps.yahoo.com/py/ddResults/py